tevapharm.com - שווי שוק בספרים TEVA

Teva Pharmaceutical Industries (TEVA) relies on robust supply chains for raw materials and finished medicines, eliminating distribution disruptions. The company holds a massive share of the US prescription drug market, although it follows market pricing. This chart on GURU.Markets recorded the value 7.74. The holding's financial position is stabilizing due to steady demand for core medications and an active reduction of debt obligations.

Teva Pharmaceutical Industries operates colossal asset volumes within the global healthcare sector. By analyzing the dynamics of the book value of net assets, an investor can see the actual rate of change in equity minus liabilities. This metric measures the fundamental value of assets, reflecting the business's ability to accumulate resources. Amid severe pricing pressure on generics, this indicator reveals the effectiveness of capital protection. The stability of the trend confirms the viability of the model despite low pricing power.